Selecting the right injection technique is a critical part of your treatment plan tailored to your lifestyle and goals
Considered for adults with clinical eligibility for dual-incretin therapy Your clinician reviews your history for thyroid conditions (MTC/MEN2), pancreatitis, and pregnancy Not prescribed during pregnancy, active thyroid malignancy, or certain GI conditions Labs and vitals may be ordered
Identified CoUs include biomarkers of risk (e.g., APOE4 ), diagnosis (e.g., amyloid PET, CSF AD biomarkers), monitoring (e.g., blood-based biomarkers of p-tau and NfL), pharmacodynamic response (e.g., amyloid PET, tau PET), prognosis (p-tau, Up53), treatment response prediction (none known for predicting benefit
15 In mammals, this process is catalyzed by enzymes encoded by genes such as CntA/B, CutC, and betaine reductase